• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黄瘤病在纯合子家族性高胆固醇血症患者中易被误诊和误治:呼吁皮肤科医生和医疗保健从业者提高认识。

Xanthomas Can Be Misdiagnosed and Mistreated in Homozygous Familial Hypercholesterolemia Patients: A Call for Increased Awareness Among Dermatologists and Health Care Practitioners.

机构信息

Cardiovascular Prevention Unit, Adult Cardiology Department, Prince Sultan Cardiac Centre, Riyadh, SA.

Department of Medical Genetics, Faculty of Medicine, Umm Al-Qura University, Makkah Al Mukarramah, SA.

出版信息

Glob Heart. 2020 Feb 28;15(1):19. doi: 10.5334/gh.759.

DOI:10.5334/gh.759
PMID:32489792
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7218775/
Abstract

BACKGROUND

Familial hypercholesterolemia (FH) is an autosomal dominant inherited genetic disorder and results in the development of coronary artery disease (CAD). Clinical diagnosis of homozygous HH patients is usually straightforward because persistent hypercholesterolemia can produce xanthoma and corneal arcus. However, xanthoma may also be misdiagnosed as skin lesions and could therefore be mistreated. The aim of this case study report is to highlight the plight of patients with FH as means of raising awareness of the condition among dermatologists and health care practitioners, also to determine the genotype-phenotype correlation in severely affected homozygous FH proband patients.

METHODS

Genetic screening of FH associated genes was performed by Ion Torrent next-generation sequencing and cascade screening by capillary sequencing.

RESULTS

We present two clinical cases with prominent skin lesions seen in a dermatology clinic that were referred to plastic surgery for excision. Genetic testing was performed later, and confirmed common single nucleotide deletion variant (c.2027delG) in the alleles consequent to a frameshift mutation p.(G676Afs33). In addition to the variant, two possibly damaging variants p.(L3313I) and p.(L1212M) and three damaging variants p.(R19), p.(G83Q) and p.(S474*) in and genes respectively were identified. The gene variant p.(G83Q) was found to be novel, while others have been previously reported. Both patients were refractory to pharmacological therapies and are currently on lipoprotein apheresis (LA).

CONCLUSIONS

The present report indicates the need for increased awareness of FH, among the public and healthcare practitioners and supports the need for diagnostic screening and cascade genetic testing of this high-risk condition, which could ultimately lead to better prevention of CHD in this lethal condition.

摘要

背景

家族性高胆固醇血症(FH)是一种常染色体显性遗传的基因疾病,可导致冠状动脉疾病(CAD)的发生。杂合 HH 患者的临床诊断通常很简单,因为持续性高胆固醇血症会导致黄斑瘤和角膜弓的形成。然而,黄斑瘤也可能被误诊为皮肤病变,因此可能会被误诊和误治。本病例研究报告的目的是强调 FH 患者的困境,以提高皮肤科医生和医疗保健从业者对该病的认识,并确定严重受影响的纯合 FH 先证者患者的基因型-表型相关性。

方法

通过 Ion Torrent 下一代测序和毛细管测序进行 FH 相关基因的遗传筛查。

结果

我们介绍了两个在皮肤科诊所就诊时出现明显皮肤病变的临床病例,这些病变被转诊到整形外科进行切除。随后进行了基因检测,证实了 等位基因中常见的单核苷酸缺失变异(c.2027delG),导致移码突变 p.(G676Afs33)。除了 变异外,还鉴定了 基因中的两个可能具有破坏性的 变异 p.(L3313I)和 p.(L1212M)以及 基因中的三个破坏性变异 p.(R19)、p.(G83Q)和 p.(S474*)。 基因中的变异 p.(G83Q)是新发现的,而其他变异先前已有报道。这两个患者对药物治疗均无反应,目前正在接受脂蛋白吸附(LA)治疗。

结论

本报告表明,需要提高公众和医疗保健从业者对 FH 的认识,并支持对这种高风险疾病进行诊断性筛查和级联遗传检测,这最终可能会改善这种致命疾病的 CHD 预防。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb0c/7218775/2cd0086d0b00/gh-15-1-759-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb0c/7218775/d88427c78dfd/gh-15-1-759-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb0c/7218775/72b3558c1907/gh-15-1-759-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb0c/7218775/2cd0086d0b00/gh-15-1-759-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb0c/7218775/d88427c78dfd/gh-15-1-759-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb0c/7218775/72b3558c1907/gh-15-1-759-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb0c/7218775/2cd0086d0b00/gh-15-1-759-g3.jpg

相似文献

1
Xanthomas Can Be Misdiagnosed and Mistreated in Homozygous Familial Hypercholesterolemia Patients: A Call for Increased Awareness Among Dermatologists and Health Care Practitioners.黄瘤病在纯合子家族性高胆固醇血症患者中易被误诊和误治:呼吁皮肤科医生和医疗保健从业者提高认识。
Glob Heart. 2020 Feb 28;15(1):19. doi: 10.5334/gh.759.
2
Next generation sequencing to identify novel genetic variants causative of autosomal dominant familial hypercholesterolemia associated with increased risk of coronary heart disease.下一代测序技术用于鉴定导致常染色体显性遗传性高胆固醇血症并伴有冠心病风险增加的新型基因变异。
Gene. 2015 Jul 1;565(1):76-84. doi: 10.1016/j.gene.2015.03.064. Epub 2015 Apr 1.
3
Novel combined variants of LDLR and LDLRAP1 genes causing severe familial hypercholesterolemia.载脂蛋白 B 降解酶 1 基因和 LDLR 基因的新型复合变异导致严重家族性高胆固醇血症。
Atherosclerosis. 2018 Oct;277:425-433. doi: 10.1016/j.atherosclerosis.2018.06.878.
4
Identification of Novel and Known LDLR Variants Triggering Severe Familial Hypercholesterolemia in Saudi Families.鉴定引发沙特家族严重家族性高胆固醇血症的新型和已知 LDLR 变异体。
Curr Vasc Pharmacol. 2022;20(4):361-369. doi: 10.2174/1570161120666220304101606.
5
Compound heterozygous LDLR variant in severely affected familial hypercholesterolemia patient.严重受累的家族性高胆固醇血症患者中的复合杂合低密度脂蛋白受体变异体
Acta Biochim Pol. 2017;64(1):75-79. doi: 10.18388/abp.2016_1283. Epub 2016 Nov 23.
6
Identification of a recurrent frameshift mutation at the LDLR exon 14 (c.2027delG, p.(G676Afs*33)) causing familial hypercholesterolemia in Saudi Arab homozygous children.在沙特阿拉伯纯合子儿童中鉴定出低密度脂蛋白受体(LDLR)外显子14上的一个复发性移码突变(c.2027delG,p.(G676Afs*33)),该突变导致家族性高胆固醇血症。
Genomics. 2016 Jan;107(1):24-32. doi: 10.1016/j.ygeno.2015.12.001. Epub 2015 Dec 11.
7
A novel low-density lipoprotein receptor variant in a Ukrainian patient: a case report and overview of the disease-causing low-density lipoprotein receptor variants associated to familial hypercholesterolemia.一位乌克兰患者的新型低密度脂蛋白受体变异:病例报告及家族性高胆固醇血症相关致病性低密度脂蛋白受体变异概述。
Mol Biol Rep. 2022 Feb;49(2):1623-1630. doi: 10.1007/s11033-021-07015-3. Epub 2021 Nov 30.
8
Severe xanthomatosis in heterozygous familial hypercholesterolemia.杂合子家族性高胆固醇血症的严重黄色瘤病。
J Clin Lipidol. 2018 Jul-Aug;12(4):872-877. doi: 10.1016/j.jacl.2018.03.087. Epub 2018 Apr 3.
9
The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.丹麦家族性高胆固醇血症的分子遗传基础与诊断
Dan Med Bull. 2002 Nov;49(4):318-45.
10
DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores.在全国范围内设计(DIAMOND-FH)中诊断和管理家族性高胆固醇血症:瑞士的流行情况、临床特征和临床评分的诊断价值。
Atherosclerosis. 2018 Oct;277:282-288. doi: 10.1016/j.atherosclerosis.2018.08.009.

引用本文的文献

1
Refractoriness to eltrombopag in adult primary immune thrombocytopenia: utility of next-generation sequencing techniques.成人原发性免疫性血小板减少症对艾曲泊帕的难治性:新一代测序技术的应用
Blood Vessel Thromb Hemost. 2025 Feb 17;2(3):100061. doi: 10.1016/j.bvth.2025.100061. eCollection 2025 Aug.
2
Novel LDLR variants affecting low density lipoprotein metabolism identified in familial hypercholesterolemia.家族性高胆固醇血症中鉴定到影响低密度脂蛋白代谢的新型 LDLR 变体。
Mol Biol Rep. 2024 Jan 18;51(1):153. doi: 10.1007/s11033-023-09169-8.
3
Novel LDLR Variant in Familial Hypercholesterolemia: NGS-Based Identification, In Silico Characterization, and Pharmacogenetic Insights.

本文引用的文献

1
Compound heterozygous LDLR variant in severely affected familial hypercholesterolemia patient.严重受累的家族性高胆固醇血症患者中的复合杂合低密度脂蛋白受体变异体
Acta Biochim Pol. 2017;64(1):75-79. doi: 10.18388/abp.2016_1283. Epub 2016 Nov 23.
2
Next-generation sequencing for molecular diagnosis of autosomal recessive polycystic kidney disease.用于常染色体隐性多囊肾病分子诊断的下一代测序技术
Gene. 2016 Oct 10;591(1):214-226. doi: 10.1016/j.gene.2016.07.021. Epub 2016 Jul 9.
3
Identification of a novel nonsense variant c.1332dup, p.(D445*) in the LDLR gene that causes familial hypercholesterolemia.
家族性高胆固醇血症中的新型低密度脂蛋白受体变异体:基于二代测序的鉴定、电子克隆特征分析及药物遗传学见解
Life (Basel). 2023 Jul 11;13(7):1542. doi: 10.3390/life13071542.
4
Case Series of Genetically Confirmed Index Cases of Familial Hypercholesterolemia in Primary Care.原发性医护中经基因确认的家族性高胆固醇血症家系索引病例的病例系列。
Am J Case Rep. 2023 Apr 27;24:e939489. doi: 10.12659/AJCR.939489.
5
Recent Advances on Familial Hypercholesterolemia in Children and Adolescents.儿童和青少年家族性高胆固醇血症的最新进展
Biomedicines. 2022 Apr 30;10(5):1043. doi: 10.3390/biomedicines10051043.
6
Familial Hypercholesterolemia in the Arabian Gulf Region: Clinical results of the Gulf FH Registry.阿拉伯海湾地区的家族性高胆固醇血症:海湾 FH 注册研究的临床结果。
PLoS One. 2021 Jun 4;16(6):e0251560. doi: 10.1371/journal.pone.0251560. eCollection 2021.
7
Characterisation of LDL receptor gene mutations in a North Indian cohort of children with homozygous familial hypercholesterolaemia.鉴定一个印度北部家族性高胆固醇血症患儿队列的 LDL 受体基因突变特征。
Pediatr Endocrinol Diabetes Metab. 2021;27(1):32-36. doi: 10.5114/pedm.2020.103056.
8
The Digenic Causality in Familial Hypercholesterolemia: Revising the Genotype-Phenotype Correlations of the Disease.家族性高胆固醇血症中的双基因因果关系:修订该疾病的基因型-表型相关性
Front Genet. 2021 Jan 15;11:572045. doi: 10.3389/fgene.2020.572045. eCollection 2020.
在低密度脂蛋白受体(LDLR)基因中鉴定出一种导致家族性高胆固醇血症的新型无义变异c.1332dup,p.(D445*) 。
Hum Genome Var. 2014 Nov 20;1:14021. doi: 10.1038/hgv.2014.21. eCollection 2014.
4
An Unusual Case of Multiple Tendinous Xanthomas Involving the Extremities and the Ears.一例累及四肢和耳部的多发性肌腱黄色瘤罕见病例。
Case Rep Dermatol. 2015 Nov 28;7(3):340-4. doi: 10.1159/000441711. eCollection 2015 Sep-Dec.
5
Identification of a recurrent frameshift mutation at the LDLR exon 14 (c.2027delG, p.(G676Afs*33)) causing familial hypercholesterolemia in Saudi Arab homozygous children.在沙特阿拉伯纯合子儿童中鉴定出低密度脂蛋白受体(LDLR)外显子14上的一个复发性移码突变(c.2027delG,p.(G676Afs*33)),该突变导致家族性高胆固醇血症。
Genomics. 2016 Jan;107(1):24-32. doi: 10.1016/j.ygeno.2015.12.001. Epub 2015 Dec 11.
6
Screening for genetic mutations in LDLR gene with familial hypercholesterolemia patients in the Saudi population.对沙特人群中患有家族性高胆固醇血症的患者进行低密度脂蛋白受体(LDLR)基因突变筛查。
Acta Biochim Pol. 2015;62(3):559-62. doi: 10.18388/abp.2015_1015. Epub 2015 Sep 8.
7
Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel.纯合子家族性高胆固醇血症患者的识别与治疗:中东咨询小组的信息与建议
Curr Vasc Pharmacol. 2015;13(6):759-70. doi: 10.2174/1570161113666150827125040.
8
Homozygous autosomal dominant hypercholesterolaemia: prevalence, diagnosis, and current and future treatment perspectives.纯合子常染色体显性高胆固醇血症:患病率、诊断以及当前和未来的治疗前景。
Curr Opin Lipidol. 2015 Jun;26(3):200-9. doi: 10.1097/MOL.0000000000000179.
9
Next generation sequencing to identify novel genetic variants causative of autosomal dominant familial hypercholesterolemia associated with increased risk of coronary heart disease.下一代测序技术用于鉴定导致常染色体显性遗传性高胆固醇血症并伴有冠心病风险增加的新型基因变异。
Gene. 2015 Jul 1;565(1):76-84. doi: 10.1016/j.gene.2015.03.064. Epub 2015 Apr 1.
10
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society.纯合子家族性高胆固醇血症:临床医生提高检测和临床管理水平的新见解与指南。欧洲动脉粥样硬化学会家族性高胆固醇血症共识小组的立场文件。
Eur Heart J. 2014 Aug 21;35(32):2146-57. doi: 10.1093/eurheartj/ehu274. Epub 2014 Jul 22.